Aberrant DNA methylation can occur early in neoplastic transbisulfite which discriminates between methylcytosine and formation and may lead to the development of cancer. We cytosine and which made it possible to determine the methyl- 
(10 mM Tris-Cl pH 7.5, 400 mM NaCl, 2 mM EDTA). Two ml of 10% SDS and 650 l of pronase (20 mg/ml, Boehringer, Mannheim, Germany) were added, followed by overnight Introduction incubation at 37°C. The incubation was mixed with 5 ml of saturated NaCl and precipitates were removed by centrifugDisruption of DNA methylation patterns has recently emerged ation for 10 min at 2000 g. The DNA was precipitated with 2 as one of the possible origins of carcinogenesis. Methylation volumes of ethanol, collected with a glass rod, washed in 70% of cytosine residues at CpG sites in the promoter region of a ethanol, air dried and suspended in 0.5 ml of TE (10 mM Trisnumber of tumor suppressor genes has been observed Cl pH 7.5, 1 mM EDTA). White blood cells (WBC) from healspecifically in neoplastic cells and this hypermethylation is thy individuals were isolated from 10 ml of heparinised blood correlated with suppression of gene expression. [1] [2] [3] [4] [5] [6] The after removal of erythrocytes with 40 ml of lysis buffer regional increase in DNA methylation contrasts with a general (155 mM NH 4 Cl, 10 mM KHCO 3 , 1 mM EDTA) and centrifugdecrease of the methylcytosine content of DNA that has been ation at 2000 g. DNA was isolated from the cell pellet as observed in leukemic and other tumor cells.
7-9 A detailed described above and used as a control for the DNA methylcharacterization of aberrant DNA methylation patterns is ation studies. 10, 17 required for understanding the underlying processes. The techniques that have thus far been used to determine the methylation state of specific gene regions in leukemia have
Southern blot analysis been limited to CpG sites that are part of recognition sequences for restriction enzymes which do not cut when the Genomic DNA (10 g) was digested with HhaI or HpaII (Life cytosine is methylated. 1, [10] [11] [12] [13] [14] We made use of a special Technologies, Paisley, UK) and size fractionated by electrosequencing procedure to analyze the methylation state of 25 phoresis on a 0.8% agarose gel in TBE (90 mM Tris, 90 mM CpG sites around the start site of transcription of the calcitonin borate, 2 mM EDTA). A PstI digest of phage was used as a gene in lymphoblasts from pediatric patients with acute lymsize marker. The DNA was denatured by stirring in a mixture phoblastic leukemia (ALL). Genomic DNA was modified with of 0.5 N NaOH and 1.5 M NaCl, transferred from the gel by capillary blotting with the same solution to a nitrocellulose filter (Genescreen plus; NEN Research Products, Boston, MA, USA) and cross-linked to the filter by UV light. The filter was The 1.4-kb probe was derived from the calcitonin gene X-100, 50 mM KCl, 2.25 mM MgCl 2 , 200 M each dATP, dCTP, dGTP and dTTP, and 1.25 U Taq DNA polymerase region by PCR with primers 2291 and 2294 as described.
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This fragment was radioactively labeled by random priming (BRL). The DNA was denatured for 2 min at 94°C followed by 30 cycles of 94°C (1 min), 50°C (1 min) and 72°C (2 min). (Boehringer) according to the manufacturer's instructions. The filter was incubated overnight in hybridization buffer with the The PCR was ended with an incubation of 10 min at 72°C. The nested PCRs were performed in a volume of 100 l with probe, washed at 65°C to a final stringency of 0.3 × SSC, 0.1% SDS (1 × SSC = 150 mM NaCl, 15 mM Na-citrate) and auto-200 ng of the appropriate primers from Table 1 under the same conditions except that each nucleotide concentration radiographed.
was 400 M. The primer combinations for nested PCR were: A1 + A6, A5 + A4, A3 + A8, A7 + A2, B1 + B6, B5 + B4, B3 + B2 and B7 + B8.
Genomic sequencing of methylcytosine
The products were purified with a PCR purification kit (Qiagen, Hilden, Germany) as prescribed and cycle The genomic sequence analysis after bisulfite modification of the DNA was based on the method described by Clark et al. 15 sequenced with appropriate primers from Table 1 with the kit from Life Technologies as recommended by the manufacturer. Genomic DNA (2 g) was fragmented by shearing through a 0.4-mm gauge needle. The DNA was denatured at 0.3 N NaOH in a volume of 100 l for 15 min at 37°C and sulfonated with 900 l of 3.6 M NaHSO 3 pH 5.0, 1 mM hydroResults quinone at 55°C for 18 h. The incubation was overlaid with 200 l of mineral oil. After the reaction, the DNA was purified Southern blot analysis with the Geneclean II kit (BIO101, La Jolla, CA, USA). Glassmilk (20 l) was added directly to the reaction. The DNA The calcitonin gene region is a hot spot for DNA methylation in a variety of neoplasms, including ALL. We used two essenwas allowed to bind for 1 h, washed according to the manufacturer's protocol and eluted with 50 l of H 2 O. The DNA tially different techniques to investigate DNA hypermethylation in lymphoblasts from ALL patients at relapse in compariwas desulfonated by the addition of 50 l 0.4 N NaOH, incubated for 10 min at room temperature and neutralized by son to lymphoblasts from the same patients at initial diagnosis. Malignant lymphoblasts were isolated from six patients at addition of 22 l of 1 N acetic acid. The DNA was ethanol precipitated and resuspended in 50 l of H 2 O. first presentation of ALL and at relapse. We monitored the DNA methylation state of CCGG (HpaII) and GCGC (HhaI) PCR was performed with 10 l of bisulfite-treated DNA. The two DNA strands were no longer complementary after sites in the 5Ј region of the calcitonin gene by Southern blot analysis. These restriction enzymes do not cut the DNA when modification and different primer sets were used to amplify the strands separately. All primers that were used to PCR and a methylated CpG site is part of the recognition sequence. It appeared that control DNA from WBC of healthy individuals sequence analyze the modified 5Ј calcitonin gene region are listed in Table 1 . The initial PCRs were performed with pricontained few methylated HpaII sites in the region (Figure 1 ). Others have validated the use of this DNA as a control. 
not been deleted in this case (data not shown). We conclude
The positioning of these primers corresponds to that of accession that methylation of the calcitonin gene region has progressed
No. X15943 of the EMBL library. The primers A1-A4, A8, B1-B4
in this patient to such a level that the fragments migrate with and B9 carry mutations to introduce restriction enzyme sites.
the high molecular weight material close to the origin of the
Nucleotides were incorporated at CpG sites that would not basepair after modification, irrespective of the methylation state.
gel. Patients 3 and 6 displayed methylation of HpaII and HhaI
Figure 1
Southern blot analysis of the calcitonin gene region in ALL lymphoblasts. Genomic DNA of lymphoblasts from ALL patients at initial diagnosis and at relapse and of control DNA from WBC of healthy individuals was digested with HpaII or HhaI as indicated. The HhaI patterns of patients 2 and 4 can be compared with the control pattern of the fourth panel. The DNA was size fractionated by electrophoresis on agarose gel and transferred to a nitrocellulose filter. After incubation with the radioactive probe, the filters were washed and autoradiographed as described in the Materials and methods section. The size of the bands is indicated in kilo basepairs (kb). c = control DNA, i = lymphoblast DNA from patient at initial diagnosis of ALL, r = lymphoblast DNA from patient at relapse. The HpaII (Hp) and HhaI (Hh) maps of the region are depicted with the position of the probe and exons 1 and 2 of the gene (numbered boxes).
sites that were not methylated in control DNA but there were as thymine in DNA synthesis so the only C residues in the sequence are derived from methylcytosine in the genomic no differences between diagnosis and relapse (data not shown).
DNA. A typical result of this technique is shown in Figure 2 . The In summary, the Southern blot technique demonstrated DNA hypermethylation at initial diagnosis in five out of the control DNA from WBC of a healthy individual does not have C bands in the area, so the genomic DNA did not contain six cases and in all six cases at relapse. Two cases did not display changes between the DNA methylation patterns at methylated CpG sites at this location. The lymphoblast DNA at initial diagnosis in patient 5 is fully methylated at three posinitial diagnosis and at relapse.
itions as evidenced by the C bands in the sequence. Five other positions display both C and T bands (Figure 2 , half filled circles). For convenience we scored 1-2 methylated sites, Genomic sequencing of methylcytosine based on intensities of C and T bands, as half methylated sites and assume that this corresponds to methylation of one of the We further studied the DNA methylation pattern of the promoter region of the calcitonin gene by sequence analysis after two alleles of the genome. The level of DNA methylation had increased at relapse of patient 5. Five positions were fully bisulfite modification of genomic DNA. 15 The bisulfite treatment deaminates cytosine to uracil but leaves methylcytosine methylated and four positions were half methylated. Figures 3a and 4a compile the sequence data from, respectunchanged. The two DNA strands are no longer complementary after modification and different primer sets are designed ively, the six patients with recurrent ALL, and eight patients at initial diagnosis only. The 25 CpG sites that were investigated to PCR amplify the strands separately. Two rounds of PCR were required to obtain sufficient DNA for sequence analysis.
surround the start site for transcription of the calcitonin gene. One of the three control DNAs from WBC of healthy individNested primers were used for the second round of PCR and for the sequence analysis. Selected fragments of the calcitonin uals that were included was methylated at seven sites in the region. With this number as a reference, 13 out of 14 cases gene region are PCR amplified after modification and analyzed by cycle sequencing with radio-isotopes. Uracil reacts were hypermethylated at initial diagnosis. Only patient 1 did nation with PCR and sequence analysis to determine the DNA methylation pattern around the start site of transcription of the calcitonin gene in lymphoblasts from ALL patients (Figures 2, 3a and 4a). Southern blots with DNA digestions of methylCpG sensitive restriction enzymes were used to study changes in a larger area (Figure 1 ). The bisulfite method is better suited to assess changes of DNA methylation patterns than the Southern blot technique. The advantage of the bisulfite modification technique is that the status of each CpG site can be determined, while the techniques that use methyl-CpG sensitive restriction enzymes focus on only a small proportion of methylation sites in a DNA region. Use of the latter techniques could have led to an underestimation of the incidence of DNA hypermethylation of tumor suppressor genes in cancer.
1,2,5
Therefore, studies of DNA methylation of tumor suppressor genes with the bisulfite modification technique are required. The calcitonin gene is located on chromosome 11p15.4 and there appeared to be a positive correlation between the DNA methylation of the calcitonin gene and the methylation of two regions at chromosome 11p15.5 in tumor cells. 20 Interestingly, a putative tumor suppressor gene, CDKN1C which encodes the cyclin-dependent kinase (CDK) inhibitor p57 KIP2 ,
Figure 2
Genomic sequence of methylated cytosine residues. Single stranded DNA of lymphoblasts from an ALL patient and from WBC is also located at chromosome region 11p15. 5 . 21 There is eviof a healthy individual was treated with bisulfite as described. CDKN1C by DNA methylation could be an important factor in pediatric ALL. This question is the more interesting since the CDKN1C gene is imprinted. 22, 23 The maternal allele is not display hypermethylation at initial diagnosis and the results of patients 1, 2, 4 and 5 demonstrated an increase in preferentially expressed and, in mice, the silencing of the paternal allele is correlated with DNA methylation. Experi-DNA methylation at relapse when compared to the situation at initial diagnosis. These results correspond to those of the ments are now under way to investigate the correlation between calcitonin gene methylation and CDKN1C methylSouthern blot technique. In contrast, the bisulfite method also revealed additionally methylated sites at relapse in patients 3 ation, and whether DNA methylation of the maternal allele of CDKN1C could play a role in the development of pediatric and 6 which did not display altered DNA methylation with the Southern blot technique.
ALL. Our results clearly show at the DNA sequence level that The number of extra methylated CpG sites in the six cases ranged between 5 and 17. Patients 1, 3 and 6 had one CpG DNA methylation patterns can change between initial diagnosis and relapse of ALL. Methylation changes between the site at position 1823, 1508 and 1801, respectively, that was demethylated at relapse when compared to initial diagnosis.
initial stage and the stage at relapse were apparent in each of the six cases of ALL studied. The level of DNA methylation Patient 5 had two adjacent demethylated sites at positions 1727 and 1743. The general levels of DNA methylation of the had increased at relapse but also decreased methylation at some CpG sites was observed. Other groups suggested precalcitonin gene in the six cases are depicted in Figure 3B .
We investigated eight additional cases at initial diagnosis to viously that there is a relationship between progressed stages of chronic myeloid leukemia (CML) and increased DNA compare the levels of DNA methylation of the calcitonin gene in T lineage ALL and B lineage ALL (Figure 4a ). The total nummethylation of the calcitonin gene. 12, 13 In essence, groups of patients in either chronic phase, accelerated phase or blast ber of methylated residues at individual CpG sites is higher in the T lineage ALL cases than in the B lineage ALL cases.
crisis of CML, were compared. However, blast cells are rarely present in the peripheral blood in most chronic phase patients, Consequently, the methylation level of the T lineage ALL cases as a group is significantly higher than that of the B lineage so any aberrant DNA methylation in these cases would not be easily detected with the Southern blot technique that was ALL cases (Figure 4b , Wilcoxon test: P Ͻ 0.01).
used. Another indication for progressive DNA methylation in CML comes from the work of Zion et al 14 who studied the DNA methylation of the t(9;22) breakpoint region. These Discussion authors used PCR amplification of genomic DNA that was first digested with methyl-CpG sensitive restriction enzymes to Characterization of anomalous DNA methylation is important for the eventual identification of cis-acting DNA elements and show the presence of methylated sites. Such sites were absent or minimally present in chronic phase cells from five CML trans-acting factors that direct the hypermethylation of specific DNA regions. We set out to obtain complete maps of methylpatients but very evident in the blast crisis cells from the same patients. ated cytosine residues in primary tumor cells at the DNA sequence level. Bisulfite modification was used in combiDetailed analysis shows that the frequency of DNA methyl- ation, totalled from the 14 cases of ALL studied, varies marktwo CpG sites of the 61 that were not methylated at initial diagnosis were fully methylated at relapse. The similarities are edly between individual CpG sites (Figures 3a and 4a ). For instance, the CpG site at position 1788 is methylated in only indicative of a clonal link between the lymphoblasts taken at initial diagnosis and at relapse. Clonality is also evident from 18% of the alleles, while the site at position 1894 is methylated in 64% of the alleles. Regional differences are further the patterns of bands of the Southern blot experiments (Figure 1 ) which do not differ greatly between initial diagnosis apparent from the fact that sites that are methylated infrequently are often neighbors to other lowly methylated and relapse with the exception of case 4. The recognition motif for the transcription factor Sp1 is sites. There is also a regional difference in the frequency of alterations between the two stages of the patients with recurmethylated to a high extent in control DNA as well as patient lymphoblasts (Figures 3a and 4a ). Sp1 binding is not influrent ALL. This is illustrated by the fact that only four of the 61 alterations between the situations at initial diagnosis and at enced by CpG methylation of the recognition site. 24 Studies by several groups indicate that binding of Sp1 to methylated relapse are found at the five CpG sites in the region 1499-1579, although methylation of these CpG sites is not rare DNA promotes demethylation of the binding site and of surrounding methyl-CpG sites and, conversely, obstructs de novo since 48% of the sites were already methylated at initial diagnosis (Figure 3a) . methylation. [25] [26] [27] The extent of this effect seems to be dependent on the number of Sp1 binding sites that are located in The DNA methylation differences between diagnosis and relapse are relatively limited in most cases. For instance, only the region. 28 It is noteworthy that one demethylation is at the Sp1 binding site (Figure 3a , patient 5) and in this case the CpG DNA methylation. Such factors may, possibly together with DNA MTase, be involved in uncontrolled changes in presite upstream is also partially demethylated. Possibly, methylation of the region surrounding the single Sp1 binding site is malignant and malignant cells. The level of calcitonin gene methylation appears to be higher in T lineage ALL than in B obstructed to a limited extent by Sp1. It should be noted that evidence is lacking that this Sp1 binding motif is indeed lineage ALL (Figure 4b ). It will be interesting to investigate the role of DNA MTase in aberrant DNA methylation by comparbound by the protein in vivo.
In theory, demethylation could be the result of adminising the enzyme activity in malignant T lineage lymphoblasts to that in B lineage lymphoblasts. tration of 6-mercaptopurine and methotrexate to patients during treatment. Both drugs inhibit formation of the methylIn general, pediatric T lineage ALL has a worse prognosis than B lineage ALL but, of course, more research is required to donor S-adenosyl-methionine (SAM) and our earlier work showed that 6-mercaptopurine treatment is accompanied by establish a possible relationship between differences in DNA methylation and differences in tumor biology. In this respect, reduced methylation of newly synthesized DNA in the ALL cell line MOLT F4. 29, 30 it is important to note that there seems to be no correlation between the level of DNA methylation at the initial stage and Both the metabolism of the SAM and enhancement of the DNA methyltransferase (DNA MTase) activity have been outcome of the disease. Patients 1-6 have died from ALL, patients 8-12 and 14 continue in complete remission more implicated in the alteration of DNA methylation patterns and neoplastic transformation. [31] [32] [33] [34] [35] [36] [37] [38] The preferred DNA substrate of than 5 years from diagnosis while patients 7 and 13 have relapsed, but have been in second complete remission for DNA MTase is a double stranded CpG site which is already methylated at one of the strands. 39 The enzyme thus acts to over 5 years. Carcinogenesis may originate from alterations of DNA maintain DNA methylation patterns after DNA synthesis. Factors other than the maintenance of DNA MTase activity are methylation. Ongoing change of DNA methylation patterns in tumor cells, as demonstrated here, may also be important for probably involved in controlled, programmed changes in
